{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T05:40:38Z","timestamp":1782193238827,"version":"3.54.5"},"reference-count":142,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Investigaci\u00f3n Cl\u00ednica"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ric.2026.100035","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:04:34Z","timestamp":1769519074000},"page":"100035","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Protein tyrosine phosphatase 1B in solid tumors: Unraveling its clinical significance"],"prefix":"10.1016","volume":"78","author":[{"given":"Jos\u00e9","family":"Esparza-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Aranda-Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Escobar-Arriaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Citlali","family":"Frayde-Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Andrea","family":"Mac Donald Jamarillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eucario","family":"Leon-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda de Jes\u00fas","family":"Ibarra-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ric.2026.100035_bib0715","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3892\/ijmm.2017.3036","article-title":"The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review)","volume":"40","author":"Ardito","year":"2017","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.ric.2026.100035_bib0720","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.690306","article-title":"Targeting phosphatases and kinases: how to checkmate cancer","volume":"9","author":"Turdo","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.ric.2026.100035_bib0725","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.cell.2010.08.023","article-title":"Phosphotyrosine signaling: evolving a new cellular communication system","volume":"142","author":"Lim","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ric.2026.100035_bib0730","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ccr.2007.02.022","article-title":"A brake becomes an accelerator: PTP1B \u2013 a new therapeutic target for breast cancer","volume":"11","author":"Tonks","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ric.2026.100035_bib0735","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/aps.2014.80","article-title":"Protein tyrosine phosphatases as potential therapeutic targets","volume":"35","author":"He","year":"2014","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.ric.2026.100035_bib0740","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1056\/NEJMoa2306434","article-title":"Osimertinib with or without chemotherapy in EGFR-mutated advanced NSCLC","volume":"389","author":"Planchard","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ric.2026.100035_bib0745","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa2026982","article-title":"Nivolumab plus cabozantinib versus sunitinib for advanced renal-cell carcinoma","volume":"384","author":"Choueiri","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ric.2026.100035_bib0750","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13045-020-00977-0","article-title":"Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001\u20132020)","volume":"13","author":"Huang","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.ric.2026.100035_bib0755","doi-asserted-by":"crossref","first-page":"6722","DOI":"10.1016\/S0021-9258(18)68702-2","article-title":"Purification of the major protein-tyrosine-phosphatases of human placenta","volume":"263","author":"Tonks","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ric.2026.100035_bib0760","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tibs.2010.03.004","article-title":"PTP1B: a double agent in metabolism and oncogenesis","volume":"35","author":"Yip","year":"2010","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.ric.2026.100035_bib0765","doi-asserted-by":"crossref","first-page":"7879","DOI":"10.3892\/mmr.2017.7641","article-title":"PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics (Review)","volume":"16","author":"Ying","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.ric.2026.100035_bib0770","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1126\/science.283.5407.1544","article-title":"Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene","volume":"283","author":"Elchebly","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ric.2026.100035_bib0775","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.21037\/tcr.2020.03.14","article-title":"Association between diabetes, obesity, aging, and cancer: review of recent literature","volume":"9","author":"Qiang","year":"2020","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.ric.2026.100035_bib0780","article-title":"Overcoming cancer risk in inflammatory bowel disease: new insights into preventive strategies and pathogenesis mechanisms including interactions of immune cells, cancer signaling pathways, and gut microbiota","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ric.2026.100035_bib0785","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1158\/1078-0432.CCR-16-0934","article-title":"Molecular pathways: targeting protein tyrosine phosphatases in cancer","volume":"23","author":"Bollu","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ric.2026.100035_bib0790","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1042\/BSR20211994","article-title":"Recent advances in PTP1B signaling in metabolism cancer","volume":"41","author":"Villamar-Cruz","year":"2021","journal-title":"Biosci Rep"},{"key":"10.1016\/j.ric.2026.100035_bib0795","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1158\/0008-5472.CAN-15-1501","article-title":"PTP1B deficiency enables the ability of a high-fat diet to drive the invasive character of PTEN-deficient prostate cancers","volume":"76","author":"Labbe","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.ric.2026.100035_bib0800","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1158\/2159-8290.CD-21-0694","article-title":"PTP1B is an intracellular checkpoint that limits T-cell and CAR T-cell antitumor immunity","volume":"12","author":"Wiede","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ric.2026.100035_bib0805","doi-asserted-by":"crossref","first-page":"e520","DOI":"10.1016\/S2666-7568(23)00176-9","article-title":"Obesity-associated cancer prevention","volume":"4","author":"Chiappetta","year":"2023","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.ric.2026.100035_bib0810","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1200\/JCO.2016.67.4283","article-title":"Obesity cancer mechanisms: tumor microenvironment and inflammation","volume":"34","author":"Iyengar","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ric.2026.100035_bib0815","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s00125-012-2782-z","article-title":"Endoplasmic reticulum stress upregulates protein tyrosine phosphatase 1B and impairs glucose uptake in cultured myotubes","volume":"56","author":"Panzhinskiy","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.ric.2026.100035_bib0820","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ric.2026.100035_bib0825","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/ijc.29364","article-title":"The effects of population-based mammography screening starting between age 40 and 50 in the presence of adjuvant systemic therapy","volume":"137","author":"de Gelder","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ric.2026.100035_bib0830","first-page":"66","article-title":"Breast cancer intra-tumor heterogeneity: one tumor, different entities","volume":"69","author":"Esparza-Lopez","year":"2017","journal-title":"Rev Invest Clin"},{"key":"10.1016\/j.ric.2026.100035_bib0835","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1186\/s12885-016-2769-0","article-title":"Primary breast cancer cell culture yields intra-tumor heterogeneous subpopulations expressing exclusive patterns of receptor tyrosine kinases","volume":"16","author":"Esparza-Lopez","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ric.2026.100035_bib0840","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1158\/0008-5472.CAN-06-4610","article-title":"Protein-tyrosine phosphatase 1B is required for HER2\/Neu-induced breast cancer","volume":"67","author":"Bentires-Alj","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.ric.2026.100035_bib0845","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1158\/1541-7786.MCR-11-0198","article-title":"Epithelial protein-tyrosine phosphatase 1B contributes to the induction of mammary tumors by HER2\/Neu but is not essential for tumor maintenance","volume":"9","author":"Balavenkatraman","year":"2011","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.ric.2026.100035_bib0850","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/ncb3376","article-title":"PTP1B controls non-mitochondrial oxygen consumption by regulating RNF213 to promote tumour survival during hypoxia","volume":"18","author":"Banh","year":"2016","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.ric.2026.100035_bib0855","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1158\/0008-5472.CAN-08-4001","article-title":"Activation of Src by protein tyrosine phosphatase 1B Is required for ErbB2 transformation of human breast epithelial cells","volume":"69","author":"Arias-Romero","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.ric.2026.100035_bib0860","doi-asserted-by":"crossref","first-page":"41439","DOI":"10.1074\/jbc.M004852200","article-title":"Identification of protein-tyrosine phosphatase 1B as the major tyrosine phosphatase activity capable of dephosphorylating and activating c-Src in several human breast cancer cell lines","volume":"275","author":"Bjorge","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ric.2026.100035_bib0865","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1083\/jcb.200708048","article-title":"Calpain 2 and PTP1B function in a novel pathway with Src to regulate invadopodia dynamics and breast cancer cell invasion","volume":"180","author":"Cortesio","year":"2008","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ric.2026.100035_bib0870","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1083\/jcb.200407076","article-title":"Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2\/3 complex pathway and cofilin","volume":"168","author":"Yamaguchi","year":"2005","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ric.2026.100035_bib0875","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bbrc.2009.12.176","article-title":"Protein tyrosine phosphatase-1B and T-cell protein tyrosine phosphatase regulate IGF-2-induced MCF-7 cell migration","volume":"392","author":"Blanquart","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ric.2026.100035_bib0880","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/febs.14724","article-title":"PTP1B markedly promotes breast cancer progression is regulated by miR-193a-3p","volume":"286","author":"Yu","year":"2019","journal-title":"FEBS J"},{"key":"10.1016\/j.ric.2026.100035_bib0885","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10549-012-2373-1","article-title":"PTP1B expression is an independent positive prognostic factor in human breast cancer","volume":"137","author":"Soysal","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ric.2026.100035_bib0890","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1232047","article-title":"PTPN1 is a prognostic biomarker related to cancer immunity and drug sensitivity: from pan-cancer analysis to validation in breast cancer","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ric.2026.100035_bib0895","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0002-9378(94)70118-0","article-title":"Overexpression of the tyrosine phosphatase PTP1B is associated with human ovarian carcinomas","volume":"170","author":"Wiener","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ric.2026.100035_bib0900","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.3520","article-title":"Association of obesity with survival outcomes in patients with cancer: a systematic review and meta-analysis","volume":"4","author":"Petrelli","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ric.2026.100035_bib0905","doi-asserted-by":"crossref","first-page":"e2337780","DOI":"10.1001\/jamanetworkopen.2023.37780","article-title":"Obesity and risk of recurrence in patients with breast cancer treated with aromatase inhibitors","volume":"6","author":"Harborg","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ric.2026.100035_bib0910","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1210\/en.2012-1561","article-title":"Estrogens and PTP1B function in a novel pathway to regulate aromatase enzymatic activity in breast cancer cells","volume":"153","author":"Barone","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.ric.2026.100035_bib0915","first-page":"1471","article-title":"Esophageal cancer epidemiology in blacks and whites: racial and gender disparities in incidence, mortality, survival rates and histology","volume":"97","author":"Baquet","year":"2005","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.ric.2026.100035_bib0920","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/exmp.2000.2303","article-title":"Expression of protein tyrosine phosphatases and its significance in esophageal cancer","volume":"68","author":"Warabi","year":"2000","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.ric.2026.100035_bib0925","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1158\/1541-7786.MCR-12-0704","article-title":"PTP1B contributes to calreticulin-induced metastatic phenotypes in esophageal squamous cell carcinoma","volume":"11","author":"Wang","year":"2013","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.ric.2026.100035_bib0930","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbrc.2019.10.168","article-title":"PTP1B up-regulates EGFR expression by dephosphorylating MYH9 at Y1408 to promote cell migration and invasion in esophageal squamous cell carcinoma","volume":"522","author":"Pan","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ric.2026.100035_bib0935","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.7150\/jca.25469","article-title":"S100A4-MYH9 axis promote migration and invasion of gastric cancer cells by inducing TGF-beta-mediated epithelial\u2013mesenchymal transition","volume":"9","author":"Li","year":"2018","journal-title":"J Cancer"},{"key":"10.1016\/j.ric.2026.100035_bib0940","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.gene.2018.04.048","article-title":"MYH9: structure, functions and role of non-muscle myosin IIA in human disease","volume":"664","author":"Pecci","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.ric.2026.100035_bib0945","doi-asserted-by":"crossref","first-page":"15291","DOI":"10.3390\/ijms131115291","article-title":"Clinicopathological significance of NMIIA overexpression in human gastric cancer","volume":"13","author":"Liu","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ric.2026.100035_bib0950","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1442-2050.2011.01261.x","article-title":"Nonmuscle myosin IIA is associated with poor prognosis of esophageal squamous cancer","volume":"25","author":"Xia","year":"2012","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.ric.2026.100035_bib0955","doi-asserted-by":"crossref","first-page":"156","DOI":"10.18632\/oncotarget.10613","article-title":"Prognostic impact of MYH9 expression on patients with acute myeloid leukemia","volume":"8","author":"Yu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ric.2026.100035_bib0960","doi-asserted-by":"crossref","first-page":"52","DOI":"10.21037\/tgh.2020.01.02","article-title":"Diffuse gastric cancer: histologic, molecular, and genetic basis of disease","volume":"5","author":"Iyer","year":"2020","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.ric.2026.100035_bib0965","doi-asserted-by":"crossref","first-page":"31146","DOI":"10.18632\/oncotarget.25757","article-title":"Helicobacter pylori associated factors in the development of gastric cancer with special reference to the early-onset subtype","volume":"9","author":"Puculek","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ric.2026.100035_bib0970","doi-asserted-by":"crossref","first-page":"25","DOI":"10.21037\/cco-23-36","article-title":"CDH1 and hereditary diffuse gastric cancer: a narrative review","volume":"12","author":"Gregory","year":"2023","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.ric.2026.100035_bib0975","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1158\/1078-0432.612.11.2","article-title":"Gene copy number change events at chromosome 20 and their association with recurrence in gastric cancer patients","volume":"11","author":"Yang","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ric.2026.100035_bib0980","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/s41419-018-0611-0","article-title":"miR-338-3p functions as a tumor suppressor in gastric cancer by targeting PTP1B","volume":"9","author":"Sun","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ric.2026.100035_bib0985","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1080\/15384101.2014.998047","article-title":"Frequent amplification of PTP1B is associated with poor survival of gastric cancer patients","volume":"14","author":"Wang","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ric.2026.100035_bib0990","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1007\/s12032-011-9911-2","article-title":"PTP1B expression contributes to gastric cancer progression","volume":"29","author":"Wang","year":"2012","journal-title":"Med Oncol"},{"key":"10.1016\/j.ric.2026.100035_bib0995","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1042\/CBI20090447","article-title":"Suppression of PTP1B in gastric cancer cells in vitro induces a change in the genome-wide expression profile and inhibits gastric cancer cell growth","volume":"34","author":"Wang","year":"2010","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.ric.2026.100035_bib1000","doi-asserted-by":"crossref","DOI":"10.1177\/1073274817729245","article-title":"Epidemiology of hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"24","author":"Massarweh","year":"2017","journal-title":"Cancer Control"},{"key":"10.1016\/j.ric.2026.100035_bib1005","doi-asserted-by":"crossref","first-page":"62","DOI":"10.17998\/jlc.2024.03.13","article-title":"Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide","volume":"24","author":"Kim","year":"2024","journal-title":"J Liver Cancer"},{"key":"10.1016\/j.ric.2026.100035_bib1010","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/hep.28478","article-title":"Protein tyrosine phosphatase 1B dephosphorylates PITX1 and regulates p120RasGAP in hepatocellular carcinoma","volume":"63","author":"Tai","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ric.2026.100035_bib1015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1042\/BSR20181823","article-title":"miR-206 inhibits cell proliferation invasion migration by down-regulating PTP1B in hepatocellular carcinoma","volume":"39","author":"Yang","year":"2019","journal-title":"Biosci Rep"},{"key":"10.1016\/j.ric.2026.100035_bib1020","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/1533794","article-title":"Comprehensive bioinformatics analysis reveals PTPN1 (PTP1B) is a promising immunotherapy target associated with T cell function for liver cancer","volume":"2023","author":"Zhu","year":"2023","journal-title":"J Healthc Eng"},{"key":"10.1016\/j.ric.2026.100035_bib1025","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.bbrc.2012.03.066","article-title":"Down-regulated expression of the protein-tyrosine phosphatase 1B (PTP1B) is associated with aggressive clinicopathologic features and poor prognosis in hepatocellular carcinoma","volume":"420","author":"Zheng","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ric.2026.100035_bib1030","doi-asserted-by":"crossref","first-page":"7639","DOI":"10.18632\/aging.102276","article-title":"miR-125a-5p inhibits tumorigenesis in hepatocellular carcinoma","volume":"11","author":"Xu","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ric.2026.100035_bib1035","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/hep.26738","article-title":"Leukocyte cell-derived chemotaxin 2 antagonizes MET receptor activation to suppress hepatocellular carcinoma vascular invasion by protein tyrosine phosphatase 1B recruitment","volume":"59","author":"Chen","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.ric.2026.100035_bib1040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tox.2015.08.006","article-title":"Protein tyrosine phosphatase 1B (PTP1B): a key regulator and therapeutic target in liver diseases","volume":"337","author":"Chen","year":"2015","journal-title":"Toxicology"},{"key":"10.1016\/j.ric.2026.100035_bib1045","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.hpb.2023.05.104","article-title":"Protein tyrosine phosphatase 1B modulates yes associated protein cholangiocarcinoma cell growth","volume":"25","author":"Watkins","year":"2023","journal-title":"HPB"},{"key":"10.1016\/j.ric.2026.100035_bib1050","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer: advances and challenges","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ric.2026.100035_bib1055","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/gcc.10122","article-title":"Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer","volume":"35","author":"Mahlamaki","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ric.2026.100035_bib1060","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/s41419-019-2073-4","article-title":"Inhibition of PTP1B blocks pancreatic cancer progression by targeting the PKM2\/AMPK\/mTOC1 pathway","volume":"10","author":"Xu","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ric.2026.100035_bib1065","doi-asserted-by":"crossref","first-page":"6651","DOI":"10.18632\/oncotarget.27286","article-title":"A squalamine derivative NV669, as a novel PTP1B inhibitor: in vitro and in vivo effects on pancreatic and hepatic tumor growth","volume":"10","author":"Carmona","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.ric.2026.100035_bib1070","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092025","article-title":"A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis","volume":"13","author":"Sawicki","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ric.2026.100035_bib1075","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s12885-024-12054-7","article-title":"The association between organised colorectal cancer screening strategies and reduction of its related mortality. a systematic review and meta-analysis","volume":"24","author":"Ding","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ric.2026.100035_bib1080","doi-asserted-by":"crossref","first-page":"21922","DOI":"10.18632\/oncotarget.7829","article-title":"Increased PTP1B expression and phosphatase activity in colorectal cancer results in a more invasive phenotype and worse patient outcome","volume":"7","author":"Hoekstra","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ric.2026.100035_bib1085","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10735-013-9536-1","article-title":"Overexpression of PTP1B in human colorectal cancer and its association with tumor progression and prognosis","volume":"45","author":"Chen","year":"2014","journal-title":"J Mol Histol"},{"key":"10.1016\/j.ric.2026.100035_bib1090","doi-asserted-by":"crossref","DOI":"10.1038\/srep35308","article-title":"Protein tyrosine phosphatase 1B targets PITX1\/p120RasGAP thus showing therapeutic potential in colorectal carcinoma","volume":"6","author":"Teng","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ric.2026.100035_bib1095","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1515\/hsz-2020-0124","article-title":"Vemurafenib downmodulates aggressiveness mediators of colorectal cancer (CRC): Low Molecular Weight Protein Tyrosine Phosphatase (LMWPTP) Protein Tyrosine Phosphatase 1B (PTP1B) and Transforming Growth Factor beta (TGFbeta)","volume":"401","author":"Cordeiro","year":"2020","journal-title":"Biol Chem"},{"key":"10.1016\/j.ric.2026.100035_bib1100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.urolonc.2024.06.002","article-title":"A systematic review of family history, race\/ethnicity, and genetic risk on prostate cancer detection and outcomes: considerations in PSA-based screening","volume":"43","author":"Graham","year":"2025","journal-title":"Urol Oncol"},{"key":"10.1016\/j.ric.2026.100035_bib1105","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3390\/curroncol30020178","article-title":"Underlying features of prostate cancer-statistics risk factors, and emerging methods for its diagnosis","volume":"30","author":"Berenguer","year":"2023","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ric.2026.100035_bib1110","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1158\/0008-5472.CAN-11-2602","article-title":"PTP1B is an androgen receptor-regulated phosphatase that promotes the progression of prostate cancer","volume":"72","author":"Lessard","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.ric.2026.100035_bib1115","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1334845","article-title":"Differences in the expression of the phosphatase PTP-1B in patients with localized prostate cancer with and without adverse pathological features","volume":"14","author":"Bourlon","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.ric.2026.100035_bib1120","doi-asserted-by":"crossref","first-page":"e2021869","DOI":"10.1001\/jamanetworkopen.2020.21869","article-title":"Evaluation of clear cell papillary, and chromophobe renal cell carcinoma metastasis sites and association with survival","volume":"4","author":"Dudani","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ric.2026.100035_bib1125","first-page":"45","article-title":"Renal cell carcinoma: links risks","volume":"9","author":"Kabaria","year":"2016","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"10.1016\/j.ric.2026.100035_bib1130","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1200\/EDBK_174469","article-title":"Evolving treatment paradigm in metastatic renal cell carcinoma","volume":"37","author":"Gill","year":"2017","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.ric.2026.100035_bib1135","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002004","article-title":"A HIF-regulated VHL-PTP1B-Src signaling axis identifies a therapeutic target in renal cell carcinoma","volume":"3","author":"Suwaki","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ric.2026.100035_bib1140","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","article-title":"Epidemiology of bladder cancer in 2023: a systematic review of risk factors","volume":"84","author":"Jubber","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.ric.2026.100035_bib1145","article-title":"Uncovering the inhibitory molecular mechanism of pomegranate peel to urinary bladder urothelial carcinoma using proteomics techniques","volume":"12","author":"Huang","year":"2022","journal-title":"Life (Basel)"},{"key":"10.1016\/j.ric.2026.100035_bib1150","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ccm.2011.09.001","article-title":"Lung cancer: epidemiology, etiology, and prevention","volume":"32","author":"Dela Cruz","year":"2011","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.ric.2026.100035_bib1155","article-title":"Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis","volume":"10","author":"Field","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.ric.2026.100035_bib1160","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.canlet.2015.01.020","article-title":"PTP1B promotes cell proliferation and metastasis through activating src and ERK1\/2 in non-small cell lung cancer","volume":"359","author":"Liu","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ric.2026.100035_bib1165","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1002\/jcb.29554","article-title":"miR-146b reverses epithelial\u2013mesenchymal transition via targeting PTP1B in cisplatin-resistance human lung adenocarcinoma cells","volume":"121","author":"Han","year":"2020","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.ric.2026.100035_bib1170","doi-asserted-by":"crossref","DOI":"10.3892\/or.2024.8808","article-title":"The combination of a PTP1B inhibitor TNFR2 blocker, and PD-1 antibody suppresses the progression of non-small cell lung cancer tumors by enhancing immunocompetence","volume":"52","author":"Gui","year":"2024","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ric.2026.100035_bib1175","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113918","article-title":"Ansofaxine suppressed NSCLC progression by increasing sensitization to combination immunotherapy","volume":"146","author":"Gui","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.ric.2026.100035_bib1180","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1111\/1759-7714.13465","article-title":"CAPN1 promotes malignant behavior and erlotinib resistance mediated by phosphorylation of c-Met and PIK3R2 via degrading PTPN1 in lung adenocarcinoma","volume":"11","author":"Chen","year":"2020","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.ric.2026.100035_bib1185","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/CEJ.0000000000000217","article-title":"Ovarian cancer: epidemiology risk factors","volume":"26","author":"La Vecchia","year":"2017","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.ric.2026.100035_bib1190","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2147\/IJWH.S197604","article-title":"Ovarian cancer in the world: epidemiology and risk factors","volume":"11","author":"Momenimovahed","year":"2019","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.ric.2026.100035_bib1195","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1911361","article-title":"Olaparib plus bevacizumab as first-line maintenance in ovarian cancer","volume":"381","author":"Ray-Coquard","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ric.2026.100035_bib1200","article-title":"The role of PTP1B (PTPN1) in the prognosis of solid tumors: a meta-analysis","volume":"101","author":"Zhou","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ric.2026.100035_bib1205","doi-asserted-by":"crossref","first-page":"24923","DOI":"10.1074\/jbc.M113.482737","article-title":"Protein-tyrosine phosphatase 1B antagonized signaling by insulin-like growth factor-1 receptor and kinase BRK\/PTK6 in ovarian cancer cells","volume":"288","author":"Fan","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ric.2026.100035_bib1210","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.bbrc.2018.06.094","article-title":"PTP1B promotes the malignancy of ovarian cancer cells in a JNK-dependent mechanism","volume":"503","author":"Wang","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ric.2026.100035_bib1215","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/cyt.12921","article-title":"The phosphatase PTPN1\/PTP1B is a candidate marker of better chemotherapy response in metastatic high-grade serous carcinoma","volume":"32","author":"Davidson","year":"2021","journal-title":"Cytopathology"},{"key":"10.1016\/j.ric.2026.100035_bib1220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0287399","article-title":"Genotype profiles of high-risk human papillomavirus in women of reproductive age. A community-based study","volume":"18","author":"Wulandari","year":"2023","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ric.2026.100035_bib1225","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12040886","article-title":"Endometrial cancer in reproductive-aged females: etiology and pathogenesis","volume":"12","author":"Bassette","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.ric.2026.100035_bib1230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","article-title":"Human papillomavirus and cervical cancer","volume":"16","author":"Burd","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ric.2026.100035_bib1235","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1053856","article-title":"Multi-omics analyses of tumor-associated immune-infiltrating cells with the novel immune checkpoint protein tyrosine phosphatase 1B (PTP1B) in extracellular matrix of brain-lower-grade-glioma (LGG) and uveal-melanoma (UVM)","volume":"13","author":"Bai","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ric.2026.100035_bib1240","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.3802\/jgo.2023.34.e74","article-title":"RAIDS atlas of significant genetic and protein biomarkers in cervical cancer","volume":"34","author":"Scholl","year":"2023","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.ric.2026.100035_bib1245","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ric.2026.100035_bib1250","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016\u20132020","volume":"25","author":"Ostrom","year":"2023","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ric.2026.100035_bib1255","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ncl.2016.06.014","article-title":"Epidemiology of brain tumors","volume":"34","author":"McNeill","year":"2016","journal-title":"Neurol Clin"},{"key":"10.1016\/j.ric.2026.100035_bib1260","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.1074\/jbc.M505266200","article-title":"A peroxisome proliferator-activated receptor-gamma agonist, troglitazone, facilitates caspase-8 and -9 activities by increasing the enzymatic activity of protein-tyrosine phosphatase-1B on human glioma cells","volume":"281","author":"Akasaki","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ric.2026.100035_bib1265","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/abbs\/gmaa178","article-title":"miR-34c inhibits proliferation of glioma by targeting PTP1B","volume":"53","author":"Shu","year":"2021","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.ric.2026.100035_bib1270","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/10985549.2023.2273193","article-title":"A PTP1B-Cdk3 signaling axis promotes cell cycle progression of human glioblastoma cells through an Rb-E2F dependent pathway","volume":"43","author":"Villamar-Cruz","year":"2023","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ric.2026.100035_bib1275","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0092-8674(04)00300-9","article-title":"Cyclin C\/cdk3 promotes Rb-dependent G0 exit","volume":"117","author":"Ren","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.ric.2026.100035_bib1280","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.freeradbiomed.2013.11.005","article-title":"Nox4 redox regulation of PTP1B contributes to the proliferation and migration of glioblastoma cells by modulating tyrosine phosphorylation of coronin-1C","volume":"67","author":"Mondol","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ric.2026.100035_bib1285","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/WCO.0b013e328359b0bc","article-title":"Epidermal growth factor receptor: a re-emerging target in glioblastoma","volume":"25","author":"Hegi","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.ric.2026.100035_bib1290","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/978-0-387-09595-0_12","article-title":"The role of mammalian coronins in development and disease","volume":"48","author":"Roadcap","year":"2008","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.ric.2026.100035_bib1295","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bcp.2013.12.012","article-title":"Brain metabolic dysfunction at the core of Alzheimer's disease","volume":"88","author":"de la Monte","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ric.2026.100035_bib1300","first-page":"1778","article-title":"Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease","volume":"47","author":"Mosconi","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ric.2026.100035_bib1305","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.2337\/db13-1954","article-title":"Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease","volume":"63","author":"De Felice","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.ric.2026.100035_bib1310","first-page":"10","article-title":"PTP1B inhibition promotes microglial phagocytosis in Alzheimer's disease models by enhancing SYK signaling","author":"Cen","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.ric.2026.100035_bib1315","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12974-016-0545-3","article-title":"A novel role for protein tyrosine phosphatase 1B as a positive regulator of neuroinflammation","volume":"13","author":"Song","year":"2016","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.ric.2026.100035_bib1320","article-title":"Human protein tyrosine phosphatase 1B (PTP1B): from structure to clinical inhibitor perspectives","volume":"23","author":"Liu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ric.2026.100035_bib1325","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1517\/13543784.12.2.223","article-title":"PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity","volume":"12","author":"Zhang","year":"2003","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.ric.2026.100035_bib1330","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/oby.2009.444","article-title":"Inhibition of PTP1B by trodusquemine (MSI-1436) causes fat-specific weight loss in diet-induced obese mice","volume":"18","author":"Lantz","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.ric.2026.100035_bib1335","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1463-1326.2009.01162.x","article-title":"Pharmacological profiles of a novel protein tyrosine phosphatase 1B inhibitor, JTT-551","volume":"12","author":"Fukuda","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ric.2026.100035_bib1340","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/680348","article-title":"Pharmacological effects of JTT-551, a novel protein tyrosine phosphatase 1B inhibitor, in diet-induced obesity mice","volume":"2014","author":"Ito","year":"2014","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.ric.2026.100035_bib1345","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nchembio.1528","article-title":"Targeting the disordered C terminus of PTP1B with an allosteric inhibitor","volume":"10","author":"Krishnan","year":"2014","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.ric.2026.100035_bib1350","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1021\/acsmedchemlett.1c00678","article-title":"The inhibitors of protein tyrosine phosphatase nonreceptor type 2 (PTPN2) as potential enhancers of cancer immunotherapy and type 1 (PTPN1) as treatment of metabolic diseases","volume":"13","author":"Abdel-Magid","year":"2022","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.ric.2026.100035_bib1355","doi-asserted-by":"crossref","first-page":"7117","DOI":"10.1128\/MCB.21.21.7117-7136.2001","article-title":"Structural and evolutionary relationships among protein tyrosine phosphatase domains","volume":"21","author":"Andersen","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ric.2026.100035_bib1360","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117791","article-title":"Insights into PTP1B inhibitors as antidiabetic agents: current research future perspectives","volume":"295","author":"Haider","year":"2025","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.ric.2026.100035_bib1365","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1016\/j.bmc.2016.06.035","article-title":"The design strategy of selective PTP1B inhibitors over TCPTP","volume":"24","author":"Li","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.ric.2026.100035_bib1370","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejmech.2017.03.032","article-title":"Design, synthesis and biological evaluation of PEGylated Xenopus glucagon-like peptide-1 derivatives as long-acting hypoglycemic agents","volume":"132","author":"Han","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.ric.2026.100035_bib1375","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.4155\/fmc-2018-0089","article-title":"The development of protein tyrosine phosphatase1B inhibitors defined by binding sites in crystalline complexes","volume":"10","author":"Zhang","year":"2018","journal-title":"Future Med Chem"},{"key":"10.1016\/j.ric.2026.100035_bib1380","article-title":"The mechanism of allosteric inhibition of protein tyrosine phosphatase 1B","volume":"9","author":"Li","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ric.2026.100035_bib1385","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nsmb803","article-title":"Allosteric inhibition of protein tyrosine phosphatase 1B","volume":"11","author":"Wiesmann","year":"2004","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.ric.2026.100035_bib1390","doi-asserted-by":"crossref","first-page":"11357","DOI":"10.1073\/pnas.142298199","article-title":"PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice","volume":"99","author":"Zinker","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ric.2026.100035_bib1395","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1210\/en.2008-0885","article-title":"Inhibition of protein tyrosine phosphatase-1B with antisense oligonucleotides improves insulin sensitivity and increases adiponectin concentrations in monkeys","volume":"150","author":"Swarbrick","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.ric.2026.100035_bib1400","doi-asserted-by":"crossref","first-page":"13479","DOI":"10.1007\/s13277-016-5245-1","article-title":"PTP1B promotes aggressiveness of breast cancer cells by regulating PTEN but not EMT","volume":"37","author":"Liu","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ric.2026.100035_bib1405","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ng1963","article-title":"Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis","volume":"39","author":"Julien","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.ric.2026.100035_bib1410","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/hep.28462","article-title":"Accomplices in crime: the diabolical liaison between protein tyrosine phosphatase 1B and ras in hepatocellular carcinoma","volume":"63","author":"Calvisi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ric.2026.100035_bib1415","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1074\/mcp.RA119.001361","article-title":"Proteomic maps of human gastrointestinal stromal tumor subgroups","volume":"18","author":"Liu","year":"2019","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.ric.2026.100035_bib1420","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/pros.20412","article-title":"Protein tyrosine phosphatase PTP1B is involved in neuroendocrine differentiation of prostate cancer","volume":"66","author":"Wu","year":"2006","journal-title":"Prostate"}],"container-title":["Revista de Investigaci\u00f3n Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034837626000021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034837626000021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T14:10:33Z","timestamp":1771596633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0034837626000021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":142,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0034837626000021"],"URL":"https:\/\/doi.org\/10.1016\/j.ric.2026.100035","relation":{},"ISSN":["0034-8376"],"issn-type":[{"value":"0034-8376","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein tyrosine phosphatase 1B in solid tumors: Unraveling its clinical significance","name":"articletitle","label":"Article Title"},{"value":"Revista de Investigaci\u00f3n Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ric.2026.100035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubiran.","name":"copyright","label":"Copyright"}],"article-number":"100035"}}